HALOPERIDOL PLASMA-LEVEL AFTER A TEST DOSE AS PREDICTOR FOR THE CLINICAL-RESPONSE TO TREATMENT IN ACUTE SCHIZOPHRENIC-PATIENTS

被引：7

作者：

NETO, MRL ^{[1
]}

MULLERSPAHN, F ^{[1
]}

RUTHER, E ^{[1
]}

SCHERER, J ^{[1
]}

机构：

[1] UNIV MUNICH, PSYCHIAT HOSP, D-8000 MUNICH 2, FED REP GER

来源：

PHARMACOPSYCHIATRY | 1988年 / 21卷 / 05期

关键词：

D O I：

10.1055/s-2007-1014680

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：226 / 231

页数：6

共 50 条

[41] HALOPERIDOL - PLASMA-LEVELS AND PROLACTIN RESPONSE AS PREDICTORS OF CLINICAL IMPROVEMENT IN SCHIZOPHRENIA - CHEMICAL UPSILON-RADIORECEPTOR PLASMA-LEVEL ASSAYS
SMITH, RC
BAUMGARTNER, R
MISRA, CH
MAULDIN, M
SHVARTSBURD, A
HO, BT
DEJOHN, C
ARCHIVES OF GENERAL PSYCHIATRY, 1984, 41 (11) : 1044 - 1049
[42] PLASMA-FREE HOMOVANILLIC-ACID (HVA) AS A PREDICTOR OF CLINICAL-RESPONSE IN ACUTE-PSYCHOSIS
MAZURE, CM
NELSON, JC
JATLOW, PI
BOWERS, MB
BIOLOGICAL PSYCHIATRY, 1991, 30 (05) : 475 - 482
[43] HALOPERIDOL AND LORAZEPAM COMBINED - CLINICAL EFFECTS AND DRUG PLASMA-LEVELS IN THE TREATMENT OF ACUTE SCHIZOPHRENIC PSYCHOSIS
STEVENS, A
STEVENS, I
MAHAL, A
GAERTNER, HJ
PHARMACOPSYCHIATRY, 1992, 25 (06) : 273 - 277
[44] CORRELATION BETWEEN PLASMA-LEVEL AND CLINICAL RESPONSE IN MANIC PSYCHOTICS GIVEN HIGH DOSE FLUPHENAZINE ENANTHATE
DENCKER, SJ
JOHANSSON, R
LINDBERG, D
ACTA PSYCHIATRICA SCANDINAVICA, 1976, : 22 - 23
[45] ENDOCRINOLOGICAL FUNCTION IN SCHIZOPHRENIC-PATIENTS UNDER HALOPERIDOL TREATMENT - PLASMA PRL, HGH AND 5HT LEVELS AFTER L-5HTP LOADING
HOSHINO, Y
KANEKO, M
KUMASHIRO, H
TACHIBANA, R
FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1985, 39 (01): : 25 - 31
[46] HIGH DOSAGE HALOPERIDOL THERAPY IN CHRONIC-SCHIZOPHRENIC PATIENTS - DOUBLE-BLIND-STUDY OF CLINICAL-RESPONSE, SIDE-EFFECTS, SERUM HALOPERIDOL, AND SERUM PROLACTIN
BJORNDAL, N
BJERRE, M
GERLACH, J
KRISTJANSEN, P
MAGELUND, G
OESTRICH, IH
WAEHRENS, J
PSYCHOPHARMACOLOGY, 1980, 67 (01) : 17 - 23
[47] A DOUBLE-BLIND CONTROLLED-STUDY OF INTRAMUSCULAR ZUCLOPENTHIXOL ACETATE AND LIQUID ORAL HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH ACUTE EXACERBATION
CHOUINARD, G
SAFADI, G
BEAUCLAIR, L
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1994, 14 (06) : 377 - 384
[48] PHARMACOCLINICAL, CORRELATIONS IN SCHIZOPHRENIC-PATIENTS TREATED WITH HALOPERIDOL DECANOATE - CLINICAL-EVALUATIONS, CONCENTRATIONS OF PLASMA AND RED-BLOOD-CELL HALOPERIDOL AND ITS REDUCED METABOLITE, AND PLASMA HOMOVANILLIC-ACID
AYMARD, N
VIALA, A
STEIN, I
CAROLI, F
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1995, 19 (07): : 1119 - 1135
[49] FIBRINOGEN PHENOTYPE (PLASMA-LEVEL AND ACTIVITY) AND GENOTYPE IN ATHEROTHROMBOTIC PATIENTS EVOLUTION AFTER TICLOPIDINE TREATMENT
DROUET, L
MAZOYER, E
RIPOLL, L
DOSQUET, C
TOBELEM, G
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1379 - 1379
[50] LONGITUDINAL MEASUREMENT OF PLASMA HOMOVANILLIC-ACID LEVELS IN SCHIZOPHRENIC-PATIENTS - CORRELATION WITH PSYCHOSIS AND RESPONSE TO NEUROLEPTIC TREATMENT
PICKAR, D
LABARCA, R
DORAN, AR
WOLKOWITZ, OM
ROY, A
BREIER, A
LINNOILA, M
PAUL, SM
ARCHIVES OF GENERAL PSYCHIATRY, 1986, 43 (07) : 669 - 676

← 1 2 3 4 5 →